2001: a year of major advances in anthrax toxin research - PubMed (original) (raw)
Review
2001: a year of major advances in anthrax toxin research
Michael Mourez et al. Trends Microbiol. 2002 Jun.
Abstract
Anthrax is caused when spores of Bacillus anthracis enter a host and germinate. The bacteria multiply and secrete a tripartite toxin causing local edema and, in systemic infection, death. In nature, anthrax is primarily observed in cattle and other herbivores; humans are susceptible but rarely affected. In 2001, anthrax spores were used effectively for the first time in bioterrorist attacks, resulting in 11 confirmed cases of human disease and five deaths. These events have underscored the need for improved prophylaxis, therapeutics and a molecular understanding of the toxin. The good news about anthrax is that several decisive discoveries regarding the toxin have been reported recently. Most notably, the toxin receptor was identified, the 3-D structures of two of the toxin subunits were solved and potent in vivo inhibitors were designed. These findings have improved our understanding of the intoxication mechanism and are stimulating the design of strategies to fight disease in the future.
Similar articles
- Anthrax toxin: a tripartite lethal combination.
Ascenzi P, Visca P, Ippolito G, Spallarossa A, Bolognesi M, Montecucco C. Ascenzi P, et al. FEBS Lett. 2002 Nov 20;531(3):384-8. doi: 10.1016/s0014-5793(02)03609-8. FEBS Lett. 2002. PMID: 12435580 Review. - Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination.
Cote CK, Welkos SL. Cote CK, et al. Toxins (Basel). 2015 Aug 17;7(8):3167-78. doi: 10.3390/toxins7083167. Toxins (Basel). 2015. PMID: 26287244 Free PMC article. Review. - Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.
Glinert I, Bar-David E, Sittner A, Weiss S, Schlomovitz J, Ben-Shmuel A, Mechaly A, Altboum Z, Kobiler D, Levy H. Glinert I, et al. Antimicrob Agents Chemother. 2016 Jul 22;60(8):4878-85. doi: 10.1128/AAC.00546-16. Print 2016 Aug. Antimicrob Agents Chemother. 2016. PMID: 27270276 Free PMC article. - Lethal toxin of Bacillus anthracis causes apoptosis of macrophages.
Popov SG, Villasmil R, Bernardi J, Grene E, Cardwell J, Wu A, Alibek D, Bailey C, Alibek K. Popov SG, et al. Biochem Biophys Res Commun. 2002 Apr 26;293(1):349-55. doi: 10.1016/S0006-291X(02)00227-9. Biochem Biophys Res Commun. 2002. PMID: 12054607 - Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo.
Pini A, Runci Y, Falciani C, Lelli B, Brunetti J, Pileri S, Fabbrini M, Lozzi L, Ricci C, Bernini A, Tonello F, Dal Molin F, Neri P, Niccolai N, Bracci L. Pini A, et al. Biochem J. 2006 Apr 1;395(1):157-63. doi: 10.1042/BJ20051747. Biochem J. 2006. PMID: 16398644 Free PMC article.
Cited by
- Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection.
Shen Y, Zhukovskaya NL, Zimmer MI, Soelaiman S, Bergson P, Wang CR, Gibbs CS, Tang WJ. Shen Y, et al. Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3242-7. doi: 10.1073/pnas.0306552101. Epub 2004 Feb 20. Proc Natl Acad Sci U S A. 2004. PMID: 14978283 Free PMC article. - The receptors that mediate the direct lethality of anthrax toxin.
Liu S, Zhang Y, Hoover B, Leppla SH. Liu S, et al. Toxins (Basel). 2012 Dec 27;5(1):1-8. doi: 10.3390/toxins5010001. Toxins (Basel). 2012. PMID: 23271637 Free PMC article. - Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.
Osorio M, Wu Y, Singh S, Merkel TJ, Bhattacharyya S, Blake MS, Kopecko DJ. Osorio M, et al. Infect Immun. 2009 Apr;77(4):1475-82. doi: 10.1128/IAI.00828-08. Epub 2009 Jan 29. Infect Immun. 2009. PMID: 19179420 Free PMC article. - Inter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxication.
Opal SM, Artenstein AW, Cristofaro PA, Jhung JW, Palardy JE, Parejo NA, Lim YP. Opal SM, et al. Infect Immun. 2005 Aug;73(8):5101-5. doi: 10.1128/IAI.73.8.5101-5105.2005. Infect Immun. 2005. PMID: 16041026 Free PMC article. - Investigation of new dominant-negative inhibitors of anthrax protective antigen mutants for use in therapy and vaccination.
Cao S, Guo A, Liu Z, Tan Y, Wu G, Zhang C, Zhao Y, Chen H. Cao S, et al. Infect Immun. 2009 Oct;77(10):4679-87. doi: 10.1128/IAI.00264-09. Epub 2009 Jul 20. Infect Immun. 2009. PMID: 19620345 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources